Patricia Willisch

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 11, 2026

Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 03, 2026

Magnetic resonance imaging-guided salvage high-dose-rate brachytherapy for local recurrence after prostatectomy and external beam radiotherapy.

Journal: Journal of contemporary brachytherapy

Published: December 26, 2025

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 01, 2025

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO.

Journal: Brachytherapy

Published: June 08, 2025

High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGEC.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 18, 2025

Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 25, 2025

Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

Journal: Cancers

Published: May 21, 2024

Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

Journal: Journal of medical imaging and radiation oncology

Published: January 09, 2018

Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.

Journal: BMC palliative care

Published: May 14, 2015

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

Magnetic resonance imaging-guided salvage high-dose-rate brachytherapy for local recurrence after prostatectomy and external beam radiotherapy.

Magnetic resonance imaging-guided salvage high-dose-rate brachytherapy for local recurrence after prostatectomy and external beam radiotherapy.

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO.

Salvage brachytherapy for local recurrence of prostate cancer. Evaluation of technique and dose fractionation, impact of early diagnosis, and its effect on survival. A multicenter retrospective observational study: RESPRO.

High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGEC.

High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGEC.

Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC.

Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC.

Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain.

Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain.

Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy.

Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy.

Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.

Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.